Press Releases

Press Releases

Email page PDF view Print view Email Alert Social media sharing

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
4/25/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at 19th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference

4/25/2017

MARLBOROUGH, Mass., April 25, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
4/20/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting

4/20/2017

MARLBOROUGH, Mass., April 20, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
4/18/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes

4/18/2017

MARLBOROUGH, Mass., April 18, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
3/31/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at the American Association for Cancer Research Annual Meeting

3/31/2017

MARLBOROUGH, Mass., March 31, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
3/30/2017
7:02 AM ET
Earnings Release

RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights

3/30/2017

MARLBOROUGH, Mass., March 30, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
3/28/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals Granted Patent in Japan for Lead Clinical Candidate RXI-109

3/28/2017

MARLBOROUGH, Mass., March 28, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
3/22/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum

3/22/2017

MARLBOROUGH, Mass., March 22, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
3/21/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at the 2nd Annual Oligonucleotide and Peptide Therapeutics Conference

3/21/2017

MARLBOROUGH, Mass., March 21, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
Displaying 1 to 8 (of 160 releases)